Clinical Trial Update: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inhaled ciprofloxacin (Cipro Inhaler) in children with cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Cipro Inhaler (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Pseudomonas Infection | Phase 1 | Status: COMPLETED